Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Facial Injectable Market Insights
3.1. Facial Injectable – Industry snapshot
3.2. Facial Injectable - Ecosystem analysis
3.3. Facial Injectable Market dynamics
3.3.1. Facial Injectable – Market Forces
3.3.1.1. Facial Injectable Market driver analysis
3.3.1.2. Facial Injectable Market restraint/challenges analysis
3.3.1.3. Facial Injectable Market opportunity analysis
3.3.2. Industry analysis - Porter's five force
3.3.2.1. Bargaining power of supplier
3.3.2.2. Bargaining power of buyer
3.3.2.3. Threat of substitute
3.3.2.4. Threat of new entrant
3.3.2.5. Degree of competition
3.3.3. Facial Injectable Market PEST analysis, 2017
3.3.4. Facial Injectable Industry trends
3.3.5. Competitive Ranking Analysis
4. Facial Injectable Market Size and Forecast by Product
4.1. Key findings
4.2. Dermal Fillers/Injectable Implants
4.2.1. Global market estimates and forecasts, 2017 – 2026
4.2.1.1. Hyaluronic Acid
4.2.1.2. Collagen Fillers
4.2.1.3. Synthetic Fillers
4.2.2. Anti-aging/ Anti-wrinkle Injections
4.2.2.1. Global market estimates and forecasts, 2017 – 2026
4.2.2.1.1. Botulinum toxin A
4.2.2.1.2. Poly-L-lactic acid (PLLA) micro particles
5. Facial Injectable Market Size and Forecast by End User
5.1. Key findings
5.2. Hospitals
5.2.1. Global market estimates and forecasts, 2017 - 2026
5.3. Dermatology Clinics
5.3.1. Global market estimates and forecasts, 2017 – 2026
5.4. Beauty Clinics
5.4.1. Global market estimates and forecasts, 2017 – 2026
5.5. Dermatology Research Institutes
5.5.1. Global market estimates and forecasts, 2017 – 2026
6. Facial Injectable Market Size and Forecast by Regions
6.1. Key findings
6.2. North America
6.2.1. Facial Injectable Market by Products, 2017 - 2026
6.2.2. Facial Injectable Market by End Users, 2017 - 2026
6.2.3. U.S.
6.2.3.1. Facial Injectable Market by Products, 2017 - 2026
6.2.3.2. Facial Injectable Market by End Users, 2017 - 2026
6.2.4. Canada
6.2.4.1. Facial Injectable Market by Products, 2017 - 2026
6.2.4.2. Facial Injectable Market by End Users, 2017 - 2026
6.3. Europe
6.3.1. Facial Injectable Market by Products, 2017 - 2026
6.3.2. Facial Injectable Market by End Users, 2017 - 2026
6.3.3. Germany
6.3.3.1. Facial Injectable Market by Products, 2017 - 2026
6.3.3.2. Facial Injectable Market by End Users, 2017 - 2026
6.3.4. UK
6.3.4.1. Facial Injectable Market by Products, 2017 - 2026
6.3.4.2. Facial Injectable Market by End Users, 2017 - 2026
6.3.5. France
6.3.5.1. Facial Injectable Market by Products, 2017 - 2026
6.3.5.2. Facial Injectable Market by End Users, 2017 - 2026
6.3.6. Italy
6.3.6.1. Facial Injectable Market by Products, 2017 - 2026
6.3.6.2. Facial Injectable Market by End Users, 2017 - 2026
6.4. Asia Pacific
6.4.1. Facial Injectable Market by Products, 2017 - 2026
6.4.2. Facial Injectable Market by End Users, 2017 - 2026
6.4.3. China
6.4.3.1. Facial Injectable Market by Products, 2017 - 2026
6.4.3.2. Facial Injectable Market by End Users, 2017 - 2026
6.4.4. India
6.4.4.1. Facial Injectable Market by Products, 2017 - 2026
6.4.4.2. Facial Injectable Market by End Users, 2017 - 2026
6.4.5. Japan
6.4.5.1. Facial Injectable Market by Products, 2017 - 2026
6.4.5.2. Facial Injectable Market by End Users, 2017 - 2026
6.4.6. Australia
6.4.6.1. Facial Injectable Market by Products, 2017 - 2026
6.4.6.2. Facial Injectable Market by End Users, 2017 - 2026
6.5. Latin America
6.5.1. Facial Injectable Market by Products, 2017 - 2026
6.5.2. Facial Injectable Market by End Users, 2017 - 2026
6.5.3. Brazil
6.5.3.1. Facial Injectable Market by Products, 2017 - 2026
6.5.3.2. Facial Injectable Market by End Users, 2017 - 2026
6.5.4. Mexico
6.5.4.1. Facial Injectable Market by Products, 2017 - 2026
6.5.4.2. Facial Injectable Market by End Users, 2017 - 2026
6.6. Middle East & Africa
6.6.1. Facial Injectable Market by Products, 2017 - 2026
6.6.2. Facial Injectable Market by End Users, 2017 - 2026
7. Company Profiles
7.1. Advanced Dermatology
7.1.1. Overview
7.1.2. Financials
7.1.3. Product Benchmarking
7.1.4. Recent Developments
7.2. Merz, Inc.
7.2.1. Overview
7.2.2. Financials
7.2.3. Product Benchmarking
7.2.4. Recent Developments
7.3. Galderma Laboratories, L.P.
7.3.1. Overview
7.3.2. Financials
7.3.3. Product Benchmarking
7.3.4. Recent Developments
7.4. ColBar LifeScience Ltd.
7.4.1. Overview
7.4.2. Financials
7.4.3. Product Benchmarking
7.4.4. Recent Developments
7.5. Allergan, Plc.
7.5.1. Overview
7.5.2. Financials
7.5.3. Product Benchmarking
7.5.4. Recent Developments
7.6. Valeant Pharmaceuticals North America LLC.
7.6.1. Overview
7.6.2. Financials
7.6.3. Product Benchmarking
7.6.4. Recent Developments
7.7. Sanofi Biosurgery Inc. (Sanofi)
7.7.1. Overview
7.7.2. Financials
7.7.3. Product Benchmarking
7.8. Anika Therapeutics, Inc.
7.8.1. Overview
7.8.2. Financials
7.8.3. Product Benchmarking
7.8.4. Recent Developments
7.9. Suneva Medical, Inc.
7.9.1. Overview
7.9.2. Financials
7.9.3. Product Benchmarking
7.9.4. Recent Developments